Actionable news
All posts from Actionable news
Actionable news in AERI: Aerie Pharmaceuticals, Inc.,

No title

               Securities and Exchange Commission

                     Washington, D.C.  20549

                          Schedule 13G

            Under the Securities Exchange Act of 1934

                        (Amendment No. 4)*

June 30, 2017
(Date of event which requires filing of this statement)

Check the appropriate box to designate the rule pursuant to which

this schedule is filed:

  (X) Rule 13d-1(b)

  ( ) Rule 13d-1(c)

  ( ) Rule 13d-1(d)

Name of Issuer: Aerie Pharmaceuticals Inc.

Title of Class of Securities: Common Stock

CUSIP Number: 00771V108

*The remainder of this cover page shall be filled out for a

reporting person's initial filing on this form with respect to

the subject class of securities, and for any subsequent

amendment containing information which would alter the

disclosures provided in a prior cover page.

The information required in the remainder of this cover page

shall not be deemed to be "filed" for the purpose of Section 18

of the Securities Exchange Act of 1934 ("Act") or otherwise

subject to the liabilities of that section of the Act but shall

be subject to all other provisions of the Act (however, see the


CUSIP Number: 00771V108

1.Name of Reporting Person: Jennison Associates LLC

S.S. or I.R.S. Identification No. of Above Person: IRS

Identification #52-2069785 (formerly 13-2631108)

2. Check the Appropriate Box if a Member of a Group:  Not


3. SEC Use Only

4. Citizenship or Place of Organization: Delaware

Number of Shares Beneficially Owned By Each Reporting Person


5. Sole Voting Power:  1,885,075 shares

6. Shared Voting Power: 0 shares

7. Sole Dispositive Power: 0 shares

8. Shared Dispositive Power: 1,885,075 shares

9. Aggregate Amount Beneficially Owned by Each Reporting

Person: 1,885,075 shares

10. Check Box if the Aggregate Amount in Row 9 Excludes

Certain Shares: ( )

11. Percent of Class Represented by Amount in Row 9: 5.2%

12. Type of Reporting Person: IA

Item 1(a) Name of Issuer: Aerie Pharmaceuticals Inc.

Item 1(b) Address...